Fri, Feb 27, 2015, 8:12 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Athersys, Inc. Message Board

  • surftrader@ymail.com surftrader Feb 5, 2013 2:32 PM Flag

    Who is the ATHX guru on this message board?

    I need advice from an investor in ATHX who can provide essential information about this investment from a financial and scientific point of view. Specifically, I have had a small position in this stock since September 2012 and I am looking to add to that position this week. I currently have a nice position in PSTI, but I know that I need to diversify, hence the addition of more ATHX shares.

    Could someone knowledgeable in ATHX please brief me on how this investment compares to PSTI? What are the catalyst dates in 2013 for ATHX?

    Thank you.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seeking Alpha has articles to read just go to Y! Fin and put symbol in and look below for articles, this one is from the Cramer gang. I tried to reply earlier but Y! board is so screwed up it would not post my reply. I like ATHX, GALE, and PBIO in the healthcare sector. I will add below $1 again, the debt is less than my debt on my home here and the pipeline is solid but approval of regenerative medicine will take a while in US, already approved Asia and parts of Europe. This is a loooooooooooooooooooooong.

      From a technical perspective, ATHX spiked higher here back above its 200-day moving average of $1.33 with monster upside volume. This stock has been uptrending strong for the last three months, with shares soaring from its low of 95 cents to its recent high of $1.37. During that move, shares of ATHX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed ATHX within range of triggering a near-term breakout trade. That trade will hit if ATHX manages to take out some near-term overhead resistance levels at $1.37 to $1.47 and then once it clears more resistance at $1.60 with high volume.

      Traders should now look for long-biased trades in ATHX as long as it’s trending above some key near-term support levels at $1.22 to $1.15, and then once it sustains a move or close above those breakout levels with volume that hits near or above 411,960 shares. If that breakout triggers soon, then ATHX will set up to re-test or possibly take out its next major overhead resistance levels a $1.75 to $1.80. Any high-volume move above $1.80 will then put $2.14 to $2.33 into focus for shares of ATHX.

      From a technical perspective, ATHX spiked higher here back above its 200-day moving average of $1.33 with monster upside volume. This stock has been uptrending strong for the last three months, with shares soaring from its low of 95 cents to its recent high of $1.37. During that move, shares of ATHX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed ATHX within range of triggering a near-term breakout trade. That trade will hit if ATHX manages to take out some near-term overhead resistance levels at $1.37 to $1.47 and then once it clears more resistance at $1.60 with high volume.

      Traders should now look for long-biased trades in ATHX as long as it’s trending above some key near-term support levels at $1.22 to $1.15, and then once it sustains a move or close above those breakout levels with volume that hits near or above 411,960 shares. If that breakout triggers soon, then ATHX will set up to re-test or possibly take out its next major overhead resistance levels a $1.75 to $1.80. Any high-volume move above $1.80 will then put $2.14 to $2.33 into focus for shares of ATHX

      Sentiment: Strong Buy

    • Howdy Surf, Catz here...ATHX is a loooooooooooong stock and not for the faint of heart. It is a good buy right now at these prices (below $3), it has very little debt (less than I do on my house), and has a great pipeline established for approval of stem cell mediciine which a lot of folks do not believe is ethical. This "regenerative" medicine has been approved in Europe and Asia. It will be the future of medicine but there are other players like STEM. I like ATHX b/c the price is low enough to pull a profit when good news arrives this year. I will likely sell when I quadriple my money (a 4 bagger in trading terms). I bought in at $1.18 including brokerage fees. I plan to buy more if we drop below $1 again. I have several hundred shares so I am not a big investor, just play around with my bubble gum money as my wife calls it. I will quote from Seeking Alpha now........
      Stem cells research is still in its early stages and thus we need to look for a stock to play in their sector. We have gone over the value in shares of Athersys in our previous articles, "Athersys Should Gain At Least 50%" and "Stem Cell Stocks to Consider: Aastrom, Athersys, StemCells and Neuralstem.' Since our articles in November, Athersys has started to see both investor interest and stock price appreciation. The company has an ongoing partnership with Pfizer Inc. (PFE) worth $111m. They also have numerous ongoing trials including a Phase II study of ischemic stroke with results due this year. Athersys is still trading at a low valuation considering its strong pipeline of drugs.

      Now from Cramers group...............The Stockpickr......
      From a technical perspective, ATHX spiked higher here back above its 200-day moving average of $1.33 with monster upside volume. This stock has been uptrending strong for the last three months, with shares soaring from its low of 95 cents to its recent high of $1.37. During that move, shares of ATHX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed ATHX within range of triggering a near-term breakout trade. That trade will hit if ATHX manages to take out some near-term overhead resistance levels at $1.37 to $1.47 and then once it clears more resistance at $1.60 with high volume.

      Traders should now look for long-biased trades in ATHX as long as it’s trending above some key near-term support levels at $1.22 to $1.15, and then once it sustains a move or close above those breakout levels with volume that hits near or above 411,960 shares. If that breakout triggers soon, then ATHX will set up to re-test or possibly take out its next major overhead resistance levels a $1.75 to $1.80. Any high-volume move above $1.80 will then put $2.14 to $2.33 into focus for shares of ATHX.

      I also like GALE and PBIO in the healthcare sector, but as always do your own research like Y! Finance will let you know the financial situation of stocks, and CNN Money and Y! Finance will give you a 12 month price projection. Always buy what you know and there is a lot to know about this type of biotechnology.
      Good luck and as always I place a Strong Buy on this security,
      Catz

      Sentiment: Strong Buy

      • 1 Reply to catsaunders
      • surftrader@ymail.com surftrader Feb 7, 2013 3:41 PM Flag

        Thanks Catz, great info! I've held ATHX since last Fall and want to add to my position. I like this stock since it uses adult stem cells, not embryonic cells. Like the PLX cells in PSTI, MultiStem cells are from an adult, are injectable, do not require tissue matching, can be produced on an industrial scale and are cleared from the body over time.

        I already have a position in GALE; I'll check into PBIO. Thanks for the tip.

        I'm big on PATH, PSTI, NBS and AMBS. It's time to build my holdings in ATHX!

    • Read the last 5 articles from Seeking Alpha within the last month or so. Particularly the interview with Gil. Read the latest 10Q and 10K. That will bring you up to speed. GLTY.

      Sentiment: Strong Buy

    • do your own DD

      Sentiment: Strong Buy

      • 1 Reply to nathang0586
      • surftrader@ymail.com surftrader Feb 5, 2013 3:11 PM Flag

        Thanks Nathan. I did; that's how I ended up pursuing this stock. I've read what I could find, but there is always someone who has dug deeper than the rest of us. Time constraints do not allow a thorough investigation, thus the need for outside help. There is wisdom in seeking the advice of others. Obviously, I would check out what someone posts to make sure it is sound. I just don't want to overlook something.

        Any feedback is much appreciated.

 
ATHX
2.59+0.020(+0.78%)Feb 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.